{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:55:53Z","timestamp":1790553353932,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:00:00Z","timestamp":1790467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Basic Scientific Research Business Expenses Project of Colleges and Universities in Heilongjiang Province.","award":["2024-KYYWF-0164"],"award-info":[{"award-number":["2024-KYYWF-0164"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12788-6","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:17:04Z","timestamp":1790489824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PTBP3 promotes diabetic nephropathy via Smad3-dependent podocyte-mesenchymal transition"],"prefix":"10.1007","volume":"53","author":[{"given":"Yushu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangting","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manshu","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"12788_CR1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2174\/0929867326666190326111851","volume":"27","author":"V Peters","year":"2020","unstructured":"Peters V, Yard B, Schmitt CP (2020) Carnosine and Diabetic Nephropathy. Curr Med Chem 27:1801\u20131812. https:\/\/doi.org\/10.2174\/0929867326666190326111851","journal-title":"Curr Med Chem"},{"key":"12788_CR2","doi-asserted-by":"publisher","unstructured":"Pelle MC, Provenzano M, Busutti M, Porcu CV, Zaffina I, Stanga L, Arturi F (2022) Up-Date on Diabetic Nephropathy. Life (Basel) 12. https:\/\/doi.org\/10.3390\/life12081202","DOI":"10.3390\/life12081202"},{"key":"12788_CR3","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clin J Am Soc Nephrol 12:2032\u20132045. https:\/\/doi.org\/10.2215\/cjn.11491116","journal-title":"Clin J Am Soc Nephrol"},{"key":"12788_CR4","doi-asserted-by":"publisher","first-page":"587689","DOI":"10.3389\/fphar.2020.587689","volume":"11","author":"H Sakuma","year":"2020","unstructured":"Sakuma H, Hagiwara S, Kantharidis P, Gohda T, Suzuki Y (2020) Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs. Front Pharmacol 11:587689. https:\/\/doi.org\/10.3389\/fphar.2020.587689","journal-title":"Front Pharmacol"},{"key":"12788_CR5","doi-asserted-by":"publisher","first-page":"790937","DOI":"10.3389\/fphar.2022.790937","volume":"13","author":"MZ Wang","year":"2022","unstructured":"Wang MZ, Wang J, Cao DW, Tu Y, Liu BH, Yuan CC, Li H, Fang QJ, Chen JX, Fu Y, Wan BY, Wan ZY, Wan YG, Wu GW (2022) Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis. Front Pharmacol 13:790937. https:\/\/doi.org\/10.3389\/fphar.2022.790937","journal-title":"Front Pharmacol"},{"key":"12788_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/08923973.2015.1127382","volume":"38","author":"B Sutariya","year":"2016","unstructured":"Sutariya B, Jhonsa D, Saraf MN (2016) TGF-\u03b2: the connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol 38:39\u201349. https:\/\/doi.org\/10.3109\/08923973.2015.1127382","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"12788_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"Y Liu","year":"2006","unstructured":"Liu Y (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 69:213\u2013217. https:\/\/doi.org\/10.1038\/sj.ki.5000054","journal-title":"Kidney Int"},{"key":"12788_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41401-020-00520-4","volume":"42","author":"TT Wei","year":"2021","unstructured":"Wei TT, Yang LT, Guo F, Tao SB, Cheng L, Huang RS, Ma L, Fu P (2021) Activation of GPR120 in podocytes ameliorates kidney fibrosis and inflammation in diabetic nephropathy. Acta Pharmacol Sin 42:252\u2013263. https:\/\/doi.org\/10.1038\/s41401-020-00520-4","journal-title":"Acta Pharmacol Sin"},{"key":"12788_CR9","doi-asserted-by":"publisher","first-page":"5586","DOI":"10.1093\/nar\/gkv429","volume":"43","author":"LY Tan","year":"2015","unstructured":"Tan LY, Whitfield P, Llorian M, Monzon-Casanova E, Diaz-Munoz MD, Turner M, Smith CW (2015) Generation of functionally distinct isoforms of PTBP3 by alternative splicing and translation initiation. Nucleic Acids Res 43:5586\u20135600. https:\/\/doi.org\/10.1093\/nar\/gkv429","journal-title":"Nucleic Acids Res"},{"key":"12788_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01477","author":"B Chen","year":"2020","unstructured":"Chen B, Chen W, Mu X, Yang L, Gu X, Zhao A, Liang X, Liu J (2020) PTBP3 Induced Inhibition of Differentiation of Gastric Cancer Cells Through Alternative Splicing of Id1. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.01477","journal-title":"Front Oncol"},{"key":"12788_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02448-7","author":"Y Chen","year":"2022","unstructured":"Chen Y, Ji Y, Liu S, Liu Y, Feng W, Jin L (2022) PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-022-02448-7","journal-title":"Cancer Cell Int"},{"key":"12788_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1312-y","author":"P Hou","year":"2019","unstructured":"Hou P, Chen F, Yong H, Lin T, Li J, Pan Y, Jiang T, Li M, Chen Y, Song J, Zheng J, Bai J (2019) PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1\u03b1. J Experimental Clin Cancer Res. https:\/\/doi.org\/10.1186\/s13046-019-1312-y","journal-title":"J Experimental Clin Cancer Res"},{"key":"12788_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04564-8","author":"C Xie","year":"2022","unstructured":"Xie C, Long F, Li L, Li X, Ma M, Lu Z, Wu R, Zhang Y, Huang L, Chou J, Gong N, Hu G, Lin C (2022) PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-022-04564-8","journal-title":"Cell Death Dis"},{"key":"12788_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406633","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhao Jw, Zhang Yh, Zhu Yd, Yang Zy, Liu Sl, Tang Qy, Yang Y, Wang Hk, Shu Yj, Dong P, Wu Xs, Gong W (2024) PTBP3 Mediates IL-18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202406633","journal-title":"Adv Sci"},{"key":"12788_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/nar\/gky1190","volume":"47","author":"MS Shihabudeen Haider Ali","year":"2019","unstructured":"Shihabudeen Haider Ali MS, Cheng X, Moran M, Haemmig S, Naldrett MJ, Alvarez S, Feinberg MW, Sun X (2019) LncRNA Meg3 protects endothelial function by regulating the DNA damage response. Nucleic Acids Res 47:1505\u20131522. https:\/\/doi.org\/10.1093\/nar\/gky1190","journal-title":"Nucleic Acids Res"},{"key":"12788_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41419-023-06097-0","volume":"14","author":"N Lu","year":"2023","unstructured":"Lu N, Min J, Peng L, Huang S, Chai X, Wang S, Wang J (2023) MiR-297 inhibits tumour progression of liver cancer by targeting PTBP3. Cell Death Dis 14:564. https:\/\/doi.org\/10.1038\/s41419-023-06097-0","journal-title":"Cell Death Dis"},{"key":"12788_CR17","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1080\/15384101.2022.2052530","volume":"21","author":"C Dong","year":"2022","unstructured":"Dong C, Wu K, Gu S, Wang W, Xie S, Zhou Y (2022) PTBP3 mediates TGF-\u03b2-induced EMT and metastasis of lung adenocarcinoma. Cell Cycle 21:1406\u20131421. https:\/\/doi.org\/10.1080\/15384101.2022.2052530","journal-title":"Cell Cycle"},{"key":"12788_CR18","doi-asserted-by":"publisher","first-page":"109158","DOI":"10.1016\/j.isci.2024.109158","volume":"27","author":"Q Wang","year":"2024","unstructured":"Wang Q, Chen F, He Y, Gao Y, Wang J, Chu S, Xie P, Zhong J, Shan H, Bai J, Hou P (2024) Polypyrimidine tract-binding protein 3\/insulin-like growth factor 2 mRNA-binding proteins 3\/high-mobility group A1 axis promotes renal cancer growth and metastasis. iScience 27:109158. https:\/\/doi.org\/10.1016\/j.isci.2024.109158","journal-title":"iScience"},{"key":"12788_CR19","doi-asserted-by":"publisher","first-page":"e000817","DOI":"10.1136\/bmjdrc-2019-000817","volume":"7","author":"XQ Li","year":"2019","unstructured":"Li XQ, Chang DY, Chen M, Zhao MH (2019) Deficiency of C3a receptor attenuates the development of diabetic nephropathy. BMJ Open Diabetes Res Care 7:e000817. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000817","journal-title":"BMJ Open Diabetes Res Care"},{"key":"12788_CR20","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/s41401-024-01460-z","volume":"46","author":"XQ Li","year":"2025","unstructured":"Li XQ, Jin B, Liu SX, Zhu Y, Li N, Zhang QY, Wan C, Feng Y, Xing YX, Ma KL, Liu J, Jiang CM, Lu J (2025) Neddylation of RhoA impairs its protein degradation and promotes renal interstitial fibrosis progression in diabetic nephropathy. Acta Pharmacol Sin 46:1692\u20131705. https:\/\/doi.org\/10.1038\/s41401-024-01460-z","journal-title":"Acta Pharmacol Sin"},{"key":"12788_CR21","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41401-019-0263-3","volume":"40","author":"J Yu","year":"2019","unstructured":"Yu J, Zong GN, Wu H, Zhang KQ (2019) Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice. Acta Pharmacol Sin 40:1544\u20131554. https:\/\/doi.org\/10.1038\/s41401-019-0263-3","journal-title":"Acta Pharmacol Sin"},{"key":"12788_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.31083\/j.fbl2805100","volume":"28","author":"D Xiong","year":"2023","unstructured":"Xiong D, Hu W, Han X, Cai Y (2023) Rhein Inhibited Ferroptosis and EMT to Attenuate Diabetic Nephropathy by Regulating the Rac1\/NOX1\/\u03b2-Catenin Axis. Front Biosci (Landmark Ed) 28:100. https:\/\/doi.org\/10.31083\/j.fbl2805100","journal-title":"Front Biosci (Landmark Ed)"},{"key":"12788_CR23","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.7150\/thno.25194","volume":"8","author":"J Song","year":"2018","unstructured":"Song J, Xie C, Jiang L, Wu G, Zhu J, Zhang S, Tang M, Song L, Li J (2018) Transcription factor AP-4 promotes tumorigenic capability and activates the Wnt\/\u03b2-catenin pathway in hepatocellular carcinoma. Theranostics 8:3571\u20133583. https:\/\/doi.org\/10.7150\/thno.25194","journal-title":"Theranostics"},{"key":"12788_CR24","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12943-025-02384-w","volume":"24","author":"AM Kolarzyk","year":"2025","unstructured":"Kolarzyk AM, Kwon Y, Oh E, Lee KJ, Cho SY, Cano I, Lu R, Kwak TJ, Lee J, Wong G, Kim AH, Gandarilla O, Hidalgo M, Kim WK, Lee E (2025) Non-canonical ALK7 pathways promote pancreatic cancer metastasis through \u03b2-catenin\/MMP-mediated basement membrane breakdown and intravasation. Mol Cancer 24:188. https:\/\/doi.org\/10.1186\/s12943-025-02384-w","journal-title":"Mol Cancer"},{"key":"12788_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00441-011-1227-1","volume":"347","author":"RM Carew","year":"2012","unstructured":"Carew RM, Wang B, Kantharidis P (2012) The role of EMT in renal fibrosis. Cell Tissue Res 347:103\u2013116. https:\/\/doi.org\/10.1007\/s00441-011-1227-1","journal-title":"Cell Tissue Res"},{"key":"12788_CR26","doi-asserted-by":"publisher","unstructured":"Xu Y, Ouyang C, Lyu D, Lin Z, Zheng W, Xiao F, Xu Z, Ding L (2020) Diabetic nephropathy execrates epithelial-to-mesenchymal transition (EMT) via miR-2467-3p\/Twist1 pathway. Biomedicine & Pharmacotherapy. https:\/\/doi.org\/10.1016\/j.biopha.2020.109920","DOI":"10.1016\/j.biopha.2020.109920"},{"key":"12788_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41598-018-36911-1","volume":"9","author":"X Wang","year":"2019","unstructured":"Wang X, Gao Y, Tian N, Wang T, Shi Y, Xu J, Wu B (2019) Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-\u03baB p65 axis. Sci Rep 9:323. https:\/\/doi.org\/10.1038\/s41598-018-36911-1","journal-title":"Sci Rep"},{"key":"12788_CR28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/s41419-018-1098-4","volume":"9","author":"J Yin","year":"2018","unstructured":"Yin J, Wang Y, Chang J, Li B, Zhang J, Liu Y, Lai S, Jiang Y, Li H, Zeng X (2018) Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits \u03b25i. Cell Death Dis 9:1031. https:\/\/doi.org\/10.1038\/s41419-018-1098-4","journal-title":"Cell Death Dis"},{"key":"12788_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2220\/biomedres.46.83","volume":"46","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liu Q, Zheng Z, Zheng Q, Chen R, Zhang S (2025) Finerenone alleviates the high glucose-induced fibrosis in HK-2 cells by inhibiting EMT via the TGF-\u03b21\/Smads signaling. Biomed Res 46:83\u201392. https:\/\/doi.org\/10.2220\/biomedres.46.83","journal-title":"Biomed Res"},{"key":"12788_CR30","doi-asserted-by":"publisher","first-page":"1480626","DOI":"10.3389\/fphar.2024.1480626","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Zhuang Y, Fan G, Wang S, Yan E, Guo J, Zhang C, Jiang S (2024) Impact of baicalin and components of Scutellaria baicalensis on renal fibrosis of diabetic kidney disease. Front Pharmacol 15:1480626. https:\/\/doi.org\/10.3389\/fphar.2024.1480626","journal-title":"Front Pharmacol"},{"key":"12788_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","volume":"65","author":"S Djudjaj","year":"2019","unstructured":"Djudjaj S, Boor P (2019) Cellular and molecular mechanisms of kidney fibrosis. Mol Aspects Med 65:16\u201336. https:\/\/doi.org\/10.1016\/j.mam.2018.06.002","journal-title":"Mol Aspects Med"},{"key":"12788_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2052530","author":"C Dong","year":"2022","unstructured":"Dong C, Wu K, Gu S, Wang W, Xie S, Zhou Y (2022) PTBP3 mediates TGF-\u03b2-induced EMT and metastasis of lung adenocarcinoma. Cell Cycle. https:\/\/doi.org\/10.1080\/15384101.2022.2052530","journal-title":"Cell Cycle"},{"key":"12788_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01240-9","author":"Q Wu","year":"2020","unstructured":"Wu Q, Zhang B, Li B, Cao X, Chen X, Xue Q (2020) PTBP3 promotes migration of non-small cell lung cancer through regulating E-cadherin in EMT signaling pathway. Cancer Cell Int. https:\/\/doi.org\/10.1186\/s12935-020-01240-9","journal-title":"Cancer Cell Int"},{"key":"12788_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2017.1313164","author":"Q Ying","year":"2017","unstructured":"Ying Q, Wu G (2017) Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update. Ren Fail. https:\/\/doi.org\/10.1080\/0886022x.2017.1313164","journal-title":"Ren Fail"},{"key":"12788_CR35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.scib.2020.01.013","volume":"65","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Lu L, Liu Y, Zhang S, Li S, Wang G, Wang P, Chen L (2020) SMAD7 and SERPINE1 as novel dynamic network biomarkers detect and regulate the tipping point of TGF-beta induced EMT. Sci Bull (Beijing) 65:842\u2013853. https:\/\/doi.org\/10.1016\/j.scib.2020.01.013","journal-title":"Sci Bull (Beijing)"},{"key":"12788_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2353\/ajpath.2008.070057","volume":"172","author":"Y Li","year":"2008","unstructured":"Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y (2008) Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172:299\u2013308. https:\/\/doi.org\/10.2353\/ajpath.2008.070057","journal-title":"Am J Pathol"},{"key":"12788_CR37","doi-asserted-by":"publisher","first-page":"14450","DOI":"10.1096\/fj.201900978RR","volume":"33","author":"F Kliewe","year":"2019","unstructured":"Kliewe F, Kaling S, L\u00f6tzsch H, Artelt N, Schindler M, Rogge H, Schr\u00f6der S, Scharf C, Amann K, Daniel C, Lindenmeyer MT, Cohen CD, Endlich K, Endlich N (2019) Fibronectin is up-regulated in podocytes by mechanical stress. Faseb j 33:14450\u201314460. https:\/\/doi.org\/10.1096\/fj.201900978RR","journal-title":"Faseb j"},{"key":"12788_CR38","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.4239\/wjd.v15.i10.2111","volume":"15","author":"LG Zhuang","year":"2024","unstructured":"Zhuang LG, Zhang R, Jin GX, Pei XY, Wang Q, Ge XX (2024) Asiaticoside improves diabetic nephropathy by reducing inflammation, oxidative stress, and fibrosis: An in vitro and in vivo study. World J Diabetes 15:2111\u20132122. https:\/\/doi.org\/10.4239\/wjd.v15.i10.2111","journal-title":"World J Diabetes"},{"key":"12788_CR39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890. https:\/\/doi.org\/10.1016\/j.cell.2009.11.007","journal-title":"Cell"},{"key":"12788_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ki.2010.137","volume":"78","author":"YS Kang","year":"2010","unstructured":"Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y (2010) Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 78:363\u2013373. https:\/\/doi.org\/10.1038\/ki.2010.137","journal-title":"Kidney Int"},{"key":"12788_CR41","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.07.003","author":"K Reidy","year":"2009","unstructured":"Reidy K, Susztak K (2009) Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis. https:\/\/doi.org\/10.1053\/j.ajkd.2009.07.003","journal-title":"Am J Kidney Dis"},{"key":"12788_CR42","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/1753-0407.12914","volume":"11","author":"J Jin","year":"2019","unstructured":"Jin J, Gong J, Zhao L, Zhang H, He Q, Jiang X (2019) Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. J Diabetes 11:826\u2013836. https:\/\/doi.org\/10.1111\/1753-0407.12914","journal-title":"J Diabetes"},{"key":"12788_CR43","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12964-022-00883-7","volume":"20","author":"L Li","year":"2022","unstructured":"Li L, Feng Y, Zhang J, Zhang Q, Ren J, Sun C, Li S, Lei X, Luo G, Hu J, Huang Y (2022) Microtubule associated protein 4 phosphorylation-induced epithelial-to-mesenchymal transition of podocyte leads to proteinuria in diabetic nephropathy. Cell Commun Signal 20:115. https:\/\/doi.org\/10.1186\/s12964-022-00883-7","journal-title":"Cell Commun Signal"},{"key":"12788_CR44","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/08916934.2022.2103797","volume":"55","author":"B Li","year":"2022","unstructured":"Li B, Sun G, Yu H, Meng J, Wei F (2022) Circ_0114428 promotes proliferation, fibrosis and EMT process of high glucose-induced glomerular mesangial cells through regulating the miR-185-5p\/SMAD3 axis. Autoimmunity 55:462\u2013472. https:\/\/doi.org\/10.1080\/08916934.2022.2103797","journal-title":"Autoimmunity"},{"key":"12788_CR45","doi-asserted-by":"publisher","first-page":"e2304360","DOI":"10.1002\/advs.202304360","volume":"10","author":"Q Dan Hu","year":"2023","unstructured":"Dan Hu Q, Wang HL, Liu J, He T, Tan RZ, Zhang Q, Su HW, Kantawong F, Lan HY, Wang L (2023) Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition. Adv Sci (Weinh) 10:e2304360. https:\/\/doi.org\/10.1002\/advs.202304360","journal-title":"Adv Sci (Weinh)"},{"key":"12788_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbrc.2016.02.066","volume":"471","author":"M Du","year":"2016","unstructured":"Du M, Wang Q, Li W, Ma X, Wu L, Guo F, Zhao S, Huang F, Wang H, Qin G (2016) Overexpression of FOXO1 ameliorates the podocyte epithelial-mesenchymal transition induced by high glucose in vitro and in vivo. Biochem Biophys Res Commun 471:416\u2013422. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.066","journal-title":"Biochem Biophys Res Commun"},{"key":"12788_CR47","doi-asserted-by":"publisher","first-page":"154013","DOI":"10.1016\/j.metabol.2019.154013","volume":"103","author":"BH Xu","year":"2020","unstructured":"Xu BH, Sheng J, You YK, Huang XR, Ma RCW, Wang Q, Lan HY (2020) Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy. Metabolism 103:154013. https:\/\/doi.org\/10.1016\/j.metabol.2019.154013","journal-title":"Metabolism"},{"key":"12788_CR48","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/nep.13701","volume":"25","author":"L Jiang","year":"2020","unstructured":"Jiang L, Cui H, Ding J (2020) Smad3 signalling affects high glucose-induced podocyte injury via regulation of the cytoskeletal protein transgelin. Nephrol (Carlton) 25:659\u2013666. https:\/\/doi.org\/10.1111\/nep.13701","journal-title":"Nephrol (Carlton)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12788-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12788-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:01:48Z","timestamp":1790550108000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12788-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12788"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12788-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,27]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were approved by the Ethics Committee of the First Affiliated Hospital of Harbin Medical University.","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1628"}}